In our previous publications on various inflammatory models (atherosclerosis or multiple sclerosis), CR-50 treatment was able to deplete Reelin from the circulation, normalize the expression of endothelial adhesion proteins, decrease the rolling/adhesion/infiltration of leukocytes, and reduce the inflammation (19, 20). Here, RELN is linked to multiple sclerosis.